NEKTAR THERAPEUTICS (NKTR) Stock Analyst Earnings Estimates
NASDAQ:NKTR - Nasdaq - US6402681083 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 101.9M -33.36% | 92.1M -9.62% | 90.122M -2.15% | 101.07M 12.15% | 86.945M -13.98% | 86.323M -0.72% | 121.96M 41.28% | 135.07M 10.75% | 111.98M -17.09% | 187.22M 67.19% | 307.21M 64.09% | 479.23M 55.99% | |
| EBITDA YoY % growth | -432M -18.13% | -227.3M 47.38% | -127.41M 43.95% | -151.536M -18.94% | -157.288M -3.80% | -175.006M -11.26% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -446.1M -17.43% | -240.3M 46.13% | -135.225M 43.73% | -152.721M -12.94% | -161.564M -5.79% | -186.139M -15.21% | -210.161M -12.91% | -222.63M -5.93% | -243.069M -9.18% | -134.39M 44.71% | -28.728M 78.62% | 106.62M 471.14% | |
| Operating Margin | -437.78% | -260.91% | -150.05% | -151.10% | -185.82% | -215.63% | -172.32% | -164.83% | -217.06% | -71.78% | -9.35% | 22.25% | |
| EPS YoY % growth | -2.85 -27.23% | -1.97 30.88% | -1.05 46.70% | -0.78 25.48% | -0.82 -4.17% | -0.75 8.11% | N/A | -0.78 | -0.66 14.47% | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.17 21.99% | -0.21 -8.32% | -0.20 18.94% | -0.21 -15.98% | -0.21 -24.81% | -0.22 -9.03% | -0.23 -13.25% | -0.24 -14.82% | -0.23 -9.52% | -0.22 | -0.22 2.22% | -0.22 6.38% |
| Revenue Q2Q % growth | 30.457M 27.52% | 22.047M 1.89% | 22.47M -4.34% | 22.612M -6.27% | 23.819M -21.79% | 24.633M 11.73% | 24.852M 10.60% | 25.214M 11.51% | 25.592M 7.44% | 17.34M -29.61% | 17.34M -30.23% | 17.34M -31.23% |
| EBITDA Q2Q % growth | -32.64M -42.88% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -32.541M -6.14% | -37.926M -10.08% | -39.599M -8.53% | -40.825M -19.03% | -42.861M -31.71% | -45.049M -18.78% | -48.453M -22.36% | -52.078M -27.56% | -57.812M -34.88% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.18 25.00% | -0.22 | 0.04 | 16.31% |
| Q2 2024 Q2Q % growth | -0.25 7.41% | -0.21 | -0.04 | -20.38% |
| Q1 2024 Q2Q % growth | -0.19 40.63% | -0.19 | 0.00 | 1.96% |
| Q4 2023 Q2Q % growth | -0.22 31.25% | -0.22 | 0.00 | -1.55% |
| Q3 2023 Q2Q % growth | -0.24 22.58% | -0.20 | -0.04 | -17.98% |
| Q2 2023 Q2Q % growth | -0.27 68.24% | -0.29 | 0.02 | 6.75% |
| Q1 2023 Q2Q % growth | -0.32 34.69% | -0.26 | -0.06 | -24.21% |
| Q4 2022 Q2Q % growth | -0.32 59.49% | -0.46 | 0.14 | 30.65% |
| Q3 2022 Q2Q % growth | -0.31 55.71% | -0.46 | 0.15 | 32.39% |
| Q2 2022 Q2Q % growth | -0.85 -23.19% | -0.95 | 0.10 | 10.99% |
| Q1 2022 Q2Q % growth | -0.49 26.87% | -0.69 | 0.20 | 29.07% |
| Q4 2021 Q2Q % growth | -0.79 -21.54% | -0.83 | 0.04 | 4.31% |
| Q3 2021 Q2Q % growth | -0.70 -14.75% | -0.81 | 0.11 | 14.04% |
| Q2 2021 Q2Q % growth | -0.69 -53.33% | -0.75 | 0.06 | 7.44% |
| Q1 2021 Q2Q % growth | -0.67 -26.42% | -0.74 | 0.07 | 9.02% |
| Q4 2020 Q2Q % growth | -0.65 -1.56% | -0.69 | 0.04 | 6.27% |
| Q3 2020 Q2Q % growth | -0.61 -8.93% | -0.75 | 0.14 | 19.14% |
| Q2 2020 Q2Q % growth | -0.45 28.57% | -0.70 | 0.25 | 35.53% |
| Q1 2020 Q2Q % growth | -0.53 22.06% | -0.79 | 0.26 | 32.63% |
| Q4 2019 Q2Q % growth | -0.64 | -0.69 | 0.05 | 7.83% |
| Q3 2019 Q2Q % growth | -0.56 | -0.74 | 0.18 | 24.43% |
| Q2 2019 Q2Q % growth | -0.63 | -0.81 | 0.18 | 22.50% |
| Q1 2019 Q2Q % growth | -0.68 | -0.70 | 0.02 | 3.13% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 24.124M -0.08% | 18.646M | 5.478M | 29.38% |
| Q2 2024 Q2Q % growth | 23.489M 14.59% | 17.896M | 5.593M | 31.25% |
| Q1 2024 Q2Q % growth | 21.639M 0.21% | 15.649M | 5.99M | 38.28% |
| Q4 2023 Q2Q % growth | 23.885M 8.57% | 18.416M | 5.469M | 29.70% |
| Q3 2023 Q2Q % growth | 24.144M 2.31% | 21.739M | 2.405M | 11.06% |
| Q2 2023 Q2Q % growth | 20.499M -5.10% | 22.263M | -1.764M | -7.92% |
| Q1 2023 Q2Q % growth | 21.594M -12.93% | 20.235M | 1.359M | 6.72% |
| Q4 2022 Q2Q % growth | 22M -12.00% | 22.576M | -576K | -2.55% |
| Q3 2022 Q2Q % growth | 23.6M -5.22% | 23.061M | 539K | 2.34% |
| Q2 2022 Q2Q % growth | 21.6M -23.67% | 23.118M | -1.518M | -6.57% |
| Q1 2022 Q2Q % growth | 24.8M 5.08% | 24.865M | -65K | -0.26% |
| Q4 2021 Q2Q % growth | 25M 6.38% | 25.84M | -840K | -3.25% |
| Q3 2021 Q2Q % growth | 24.9M -17.00% | 28.425M | -3.525M | -12.40% |
| Q2 2021 Q2Q % growth | 28.3M -42.01% | 26.5M | 1.8M | 6.79% |
| Q1 2021 Q2Q % growth | 23.6M -53.36% | 27.442M | -3.842M | -14.00% |
| Q4 2020 Q2Q % growth | 23.5M -30.68% | 30.615M | -7.115M | -23.24% |
| Q3 2020 Q2Q % growth | 30M 2.74% | 26.859M | 3.141M | 11.69% |
| Q2 2020 Q2Q % growth | 48.8M 109.44% | 23.255M | 25.545M | 109.85% |
| Q1 2020 Q2Q % growth | 50.6M 79.43% | 48.595M | 2.005M | 4.13% |
| Q4 2019 Q2Q % growth | 33.9M | 27.468M | 6.432M | 23.42% |
| Q3 2019 Q2Q % growth | 29.2M | 26.924M | 2.276M | 8.45% |
| Q2 2019 Q2Q % growth | 23.3M | 27.186M | -3.886M | -14.29% |
| Q1 2019 Q2Q % growth | 28.2M | 28.188M | 12K | 0.04% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -3.67% | 16.88% | -1.19% | 6.9% |
| Revenue | -0.15% | 48.68% | -0.62% | 17.08% |